Driving Smarter Development by Measuring Patient Impact in Preclinical Decision-Making

  • Defining where patient engagement can influence early asset optimization and preclinical planning
  • Measuring insights that inform development strategy, target profiles, and outcome priorities
  • Showcasing real-world examples where early patient data measurably improves Target Product and Target Value Profiles